United States · FDA National Drug Code directory
AMITRIPTYLINE HYDROCHLORIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59651-818_8085a37f-3c76-4f74-aab3-9a929a7eb1c2
- Product NDC
- 59651-818
- Form
- TABLET, FILM COATED
- Composition / generic term
- AMITRIPTYLINE HYDROCHLORIDE
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260320
- Source listing expiry
- 20271231
Source-listed ingredients
- AMITRIPTYLINE HYDROCHLORIDE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED in 1 BOTTLE (59651-818-01) · 59651-818-01
- 1000 TABLET, FILM COATED in 1 BOTTLE (59651-818-99) · 59651-818-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →